MR Vax, Measles-Rubella
Product Overview
| Generic Name | MR Vax, Measles-Rubella |
| Brand Name(s) | BioKangtai / Beijing Minhai MR Vaccine |
| Category | Vaccines |
| Form | Vial, Lyophilized / freeze-dried live attenuated vaccine for reconstitution |
| Strength | 0.5mL |
| Therapeutic Class | Viral vaccine; live attenuated combination vaccine |
| ATC Code | J07BD53 |
Manufacturing & Regulatory
| Manufacturer | Beijing Minhai Biological Technology Co., Ltd. |
| GMP Compliance | WHO-GMP |
| DMF/CEP | No public DMF number found |
| COFEPRIS | 020.000.3800.00 |
Logistics & Export
| MOQ | 10,000 Single Dose Vials |
| Shelf Life | 18 to 24 months |
| Storage | 2–8 °C, protected from light, do not freeze |
| Incoterms | EXW |
| Lead Time | 4–8 weeks after confirmed PO, payment |
Documentation Available Upon Request
| Certificate of Analysis (PDF) | available per released batch, |
| CTD Summary (PDF) | Not publicly available |
Special Notes
Measles and Rubella Combined Vaccine, Live is a live attenuated viral vaccine intended for active immunisation against measles and rubella